Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Scalp cryotherapy significantly reduces hair loss during and shortly after chemotherapy.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

The treatment is safe and shows promise for metastatic breast cancer.

Alternative therapies like mushrooms and vinegar extracts can improve health and reduce costs for breast cancer patients.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

MVP treatment is effective and safe for recurrent breast cancer.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Comprehensive information and trained nurses are crucial for a better scalp cooling experience during chemotherapy.

Low-dose oral minoxidil combined with topical minoxidil improves hair density in breast cancer patients but may cause excess hair growth.

Mindfulness intervention greatly improves quality of life and reduces distress in women with breast cancer.

Spiritual well-being is crucial for improving quality of life in women with breast cancer.

PRP may increase hair density but doesn't improve quality of life in breast cancer survivors with hair loss.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.